3 Best Biotech Penny Stocks to Buy with February Catalysts

Although Wall Street and the mass media are obsessed with the technology sector, the biggest profits are in the biotechnology industry. Over the last 12 months, the S&P Biotechnology Select Industry Index (SPSIBI) climbed an impressive 41.31%. Meanwhile, over the same period, the S&P 500 Technology Sector SPDR ETF has returned 34.28%. That's why today we'll reveal our three best biotech penny stocks to buy. All three have upcoming February clinical trial results that could send their share prices soaring 300%-plus... Tags: Penny Stocks To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2018 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post 3 Best Biotech Penny Stocks to Buy with February Catalysts appeared first on Money Morning - We Make Investing Profitable .